- Home
- PRHI vs BNGO Comparison
PRHI vs BNGO Comparison
Compare PRHI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRHI | BNGO |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United States | United States |
| Employees | 9 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2M | 12.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PRHI | BNGO |
|---|---|---|
| Price | $5.25 | $1.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 28.5K | ★ 163.2K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000,735.00 |
| Revenue This Year | N/A | $14.99 |
| Revenue Next Year | N/A | $34.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.48 | $1.06 |
| 52 Week High | $2.83 | $5.50 |
Technical Indicators
Market Signals| Indicator | PRHI | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 95.42 | 54.72 |
| Support Level | $0.60 | $1.10 |
| Resistance Level | N/A | $1.31 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | 0.31 | 0.00 |
| Stochastic Oscillator | 100.00 | 61.57 |
Price Performance
Historical ComparisonAbout PRHI Presurance Holdings Inc.
Presurance Holdings Inc Formerly Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.